194 related articles for article (PubMed ID: 31661033)
1. Risk of major bleeding during extended oral anticoagulation in patients with first unprovoked venous thromboembolism: a systematic review and meta-analysis protocol.
Khan F; Kimpton M; Tritschler T; Le Gal G; Hutton B; Fergusson DA; Rodger MA
Syst Rev; 2019 Oct; 8(1):245. PubMed ID: 31661033
[TBL] [Abstract][Full Text] [Related]
2. Long-Term Risk for Major Bleeding During Extended Oral Anticoagulant Therapy for First Unprovoked Venous Thromboembolism : A Systematic Review and Meta-analysis.
Khan F; Tritschler T; Kimpton M; Wells PS; Kearon C; Weitz JI; Büller HR; Raskob GE; Ageno W; Couturaud F; Prandoni P; Palareti G; Legnani C; Kyrle PA; Eichinger S; Eischer L; Becattini C; Agnelli G; Vedovati MC; Geersing GJ; Takada T; Cosmi B; Aujesky D; Marconi L; Palla A; Siragusa S; Bradbury CA; Parpia S; Mallick R; Lensing AWA; Gebel M; Grosso MA; Thavorn K; Hutton B; Le Gal G; Fergusson DA; Rodger MA;
Ann Intern Med; 2021 Oct; 174(10):1420-1429. PubMed ID: 34516270
[TBL] [Abstract][Full Text] [Related]
3. Secondary prevention of recurrent venous thromboembolism after initial oral anticoagulation therapy in patients with unprovoked venous thromboembolism.
Robertson L; Yeoh SE; Ramli A
Cochrane Database Syst Rev; 2017 Dec; 12(12):CD011088. PubMed ID: 29244199
[TBL] [Abstract][Full Text] [Related]
4. Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis.
Khan F; Rahman A; Carrier M; Kearon C; Weitz JI; Schulman S; Couturaud F; Eichinger S; Kyrle PA; Becattini C; Agnelli G; Brighton TA; Lensing AWA; Prins MH; Sabri E; Hutton B; Pinede L; Cushman M; Palareti G; Wells GA; Prandoni P; Büller HR; Rodger MA;
BMJ; 2019 Jul; 366():l4363. PubMed ID: 31340984
[TBL] [Abstract][Full Text] [Related]
5. Long-Term Risk of Major Bleeding after Discontinuing Anticoagulation for Unprovoked Venous Thromboembolism: A Systematic Review and Meta-analysis.
Khan F; Rahman A; Tritschler T; Carrier M; Kearon C; Weitz JI; Schulman S; Couturaud F; Becattini C; Agnelli G; Brighton TA; Lensing AWA; Pinede L; Parpia S; Geersing GJ; Takada T; Bradbury CA; Andreozzi GM; Palareti G; Prandoni P; Buller HR; Mallick R; Hutton B; Thavorn K; Le Gal G; Rodger MA; Fergusson DA
Thromb Haemost; 2022 Jul; 122(7):1186-1197. PubMed ID: 34753191
[TBL] [Abstract][Full Text] [Related]
6. Extended Anticoagulant and Aspirin Treatment for the Secondary Prevention of Thromboembolic Disease: A Systematic Review and Meta-Analysis.
Marik PE; Cavallazzi R
PLoS One; 2015; 10(11):e0143252. PubMed ID: 26587983
[TBL] [Abstract][Full Text] [Related]
7. Long-term risk of recurrent venous thromboembolism among patients receiving extended oral anticoagulant therapy for first unprovoked venous thromboembolism: A systematic review and meta-analysis.
Khan F; Tritschler T; Kimpton M; Wells PS; Kearon C; Weitz JI; Büller HR; Raskob GE; Ageno W; Couturaud F; Prandoni P; Palareti G; Legnani C; Kyrle PA; Eichinger S; Eischer L; Becattini C; Agnelli G; Vedovati MC; Geersing GJ; Takada T; Cosmi B; Aujesky D; Marconi L; Palla A; Siragusa S; Bradbury CA; Parpia S; Mallick R; Lensing AWA; Gebel M; Grosso MA; Shi M; Thavorn K; Hutton B; Le Gal G; Rodger M; Fergusson D
J Thromb Haemost; 2021 Nov; 19(11):2801-2813. PubMed ID: 34379859
[TBL] [Abstract][Full Text] [Related]
8. Anticoagulation for the long-term treatment of venous thromboembolism in people with cancer.
Kahale LA; Hakoum MB; Tsolakian IG; Matar CF; Terrenato I; Sperati F; Barba M; Yosuico VE; Schünemann H; Akl EA
Cochrane Database Syst Rev; 2018 Jun; 6(6):CD006650. PubMed ID: 29920657
[TBL] [Abstract][Full Text] [Related]
9. Indefinite Anticoagulant Therapy for First Unprovoked Venous Thromboembolism : A Cost-Effectiveness Study.
Khan F; Coyle D; Thavorn K; van Katwyk S; Tritschler T; Hutton B; Le Gal G; Rodger MA; Fergusson DA
Ann Intern Med; 2023 Jul; 176(7):949-960. PubMed ID: 37364263
[TBL] [Abstract][Full Text] [Related]
10. Which patients with unprovoked venous thromboembolism should receive extended anticoagulation with direct oral anticoagulants? A systematic review, network meta-analysis, and decision analysis.
Djulbegovic M; Lee AI; Chen K
J Eval Clin Pract; 2020 Feb; 26(1):7-17. PubMed ID: 31190408
[TBL] [Abstract][Full Text] [Related]
11. Long-term risk of recurrence after discontinuing anticoagulants for a first unprovoked venous thromboembolism: protocol for a systematic review and meta-analysis.
Khan F; Rahman A; Carrier M; Kearon C; Schulman S; Couturaud F; Prandoni P; Eichinger S; Becattini C; Agnelli G; Büller HR; Brighton TA; Palareti G; Pinede L; Sabri E; Hutton B; Wells GA; Rodger MA;
BMJ Open; 2017 Sep; 7(9):16950. PubMed ID: 28939565
[TBL] [Abstract][Full Text] [Related]
12. Systematic review: case-fatality rates of recurrent venous thromboembolism and major bleeding events among patients treated for venous thromboembolism.
Carrier M; Le Gal G; Wells PS; Rodger MA
Ann Intern Med; 2010 May; 152(9):578-89. PubMed ID: 20439576
[TBL] [Abstract][Full Text] [Related]
13. Treatment of distal deep vein thrombosis.
Kirkilesis G; Kakkos SK; Bicknell C; Salim S; Kakavia K
Cochrane Database Syst Rev; 2020 Apr; 4(4):CD013422. PubMed ID: 32271939
[TBL] [Abstract][Full Text] [Related]
14. Shorter or longer anticoagulation to prevent recurrent venous thromboembolism: systematic review and meta-analysis.
Lopes LC; Eikelboom J; Spencer FA; Akl EA; Kearon C; Neumann I; Schulman S; Bhatnagar N; Guyatt G
BMJ Open; 2014 Jul; 4(7):e005674. PubMed ID: 24996916
[TBL] [Abstract][Full Text] [Related]
15. Anticoagulants (extended duration) for prevention of venous thromboembolism following total hip or knee replacement or hip fracture repair.
Forster R; Stewart M
Cochrane Database Syst Rev; 2016 Mar; 3(3):CD004179. PubMed ID: 27027384
[TBL] [Abstract][Full Text] [Related]
16. Systematic review: D-dimer to predict recurrent disease after stopping anticoagulant therapy for unprovoked venous thromboembolism.
Verhovsek M; Douketis JD; Yi Q; Shrivastava S; Tait RC; Baglin T; Poli D; Lim W
Ann Intern Med; 2008 Oct; 149(7):481-90, W94. PubMed ID: 18838728
[TBL] [Abstract][Full Text] [Related]
17. Fatal recurrent VTE after anticoagulant treatment for unprovoked VTE: a systematic review.
van der Wall SJ; van der Pol LM; Ende-Verhaar YM; Cannegieter SC; Schulman S; Prandoni P; Rodger M; Huisman MV; Klok FA
Eur Respir Rev; 2018 Dec; 27(150):. PubMed ID: 30487292
[TBL] [Abstract][Full Text] [Related]
18. Case Fatality Rates of Recurrent Thromboembolism and Bleeding in Patients Receiving Direct Oral Anticoagulants for the Initial and Extended Treatment of Venous Thromboembolism: A Systematic Review.
Gómez-Outes A; Lecumberri R; Suárez-Gea ML; Terleira-Fernández AI; Monreal M; Vargas-Castrillón E
J Cardiovasc Pharmacol Ther; 2015 Sep; 20(5):490-500. PubMed ID: 25802423
[TBL] [Abstract][Full Text] [Related]
19. Antiplatelet agents for the treatment of deep venous thrombosis.
Flumignan CD; Nakano LC; Baptista-Silva JC; Flumignan RL
Cochrane Database Syst Rev; 2022 Jul; 7(7):CD012369. PubMed ID: 35876829
[TBL] [Abstract][Full Text] [Related]
20. Treatment of venous thromboembolism.
Wells PS; Forgie MA; Rodger MA
JAMA; 2014 Feb; 311(7):717-28. PubMed ID: 24549552
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
